Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane

Biochimica et Biophysica Acta - Biomembranes

Volumn 1715, Issue 1, 2005, Pages 19-24

  Kobayashi, Masaki ^a   Saito, Yoshitaka ^a   Itagaki, Shirou ^a   Hirano, Takeshi ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Brush border membrane vesicle; Ceftibuten; Kidney; Nateglinide

Indexed keywords

CEFALEXIN; CEFRADINE; CEFTIBUTEN; GLYCYLSARCOSINE; NATEGLINIDE;

ABSORPTION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TRANSPORT; DRUG UPTAKE; INTESTINE EPITHELIUM; KIDNEY; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEPHALOSPORINS; CYCLOHEXANES; ION TRANSPORT; KIDNEY; MALE; MICROVILLI; PHENYLALANINE; PROTONS; RATS; RATS, WISTAR; SYMPORTERS;

EID: 23844508437     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.05.013     Document Type: Article

References (21)

1. T. Terada, K. Sawada, H. Saito, Y. Hashimoto, and K. Inui Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2 Eur. J. Pharmacol. 392 2000 11 17
2. A. Okamura, A. Emoto, N. Koyabu, H. Ohtani, and Y. Sawada Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1 Br. J. Pharmacol. 137 2002 391 399
3. S. Itagaki, Y. Saito, S. Kubo, Y. Otsuka, Y. Yamamoto, M. Kobayashi, T. Hirano, and K. Iseki H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine J. Pharmacol. Exp. Ther. 312 2005 77 82
4. Y. Uwai, H. Saito, Y. Hashimoto, and K. Inui Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1 Eur. J. Pharmacol. 398 2000 193 197
5. T. Itoh, S. Itagaki, K. Sasaki, T. Hirano, I. Takemoto, and K. Iseki Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthaleinx in rats J. Pharm. Pharmacol. 56 2004 809 812
6. C. Evers, W. Haase, H. Murer, and R. Kinne Properties of brush border vesicles isolated from rat kidney cortex by calcium precipitation Membr. Biochem. 1 1978 203 219
7. S. Itagaki, S. Shimamoto, T. Hirano, K. Iseki, M. Sugawara, S. Nishimura, M. Fujimoto, M. Kobayashi, and K. Miyazaki Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter J. Pharm. Pharm. Sci. 7 2004 227 234
8. S. Itagaki, Y. Otsuka, S. Kubo, H. Okumura, Y. Saito, M. Kobayashi, T. Hirano, and K. Iseki Intestinal uptake of nateglinide by an intestinal fluorescein transporter Biochim. Biophys. Acta 1668 2005 190 194
9. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
10. I. Naasani, K. Sato, K. Iseki, M. Sugawara, M. Kobayashi, and K. Miyazaki Comparison of the transport characteristics of ceftibuten in rat renal and intestinal brush-border membranes Biochim. Biophys. Acta 1231 1995 163 168
11. M.E. Ganapathy, M. Brandsch, P.D. Prasad, V. Ganapathy, and F.H. Leibach Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2 J. Biol. Chem. 270 1995 25672 25677
12. X.Y. Chu, G.P. Sanchez-Castano, K. Higaki, D.M. Oh, C.P. Hsu, and G.L. Amidon Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter J. Pharmacol. Exp. Ther. 299 2001 575 582
13. Y. Sato, M. Nishikawa, H. Shinkai, and E. Sukegawa Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4- isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals Diabetes Res. Clin. Pract. 12 1991 53 59
14. T. Ikenoue, M. Akiyoshi, S. Fujitani, K. Okazaki, N. Kondo, and T. Maki Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-d-phenylalanine (A-4166) Br. J. Pharmacol. 120 1997 137 145
15. W.H. Barr, C.C. Lin, E. Radwanski, J. Lim, S. Symchowicz, and M. Affrime The pharmacokinetics of ceftibuten in humans Diagn. Microbiol. Infect. Dis. 14 1991 93 100
16. R.M. Menon, and W.H. Barr Transporters involved in apical and basolateral uptake of ceftibuten into Caco-2 cells Biopharm. Drug Dispos. 23 2002 317 326
17. T. Sekine, S.H. Cha, and H. Endou The multispecific organic anion transporter (OAT) family Pflugers Arch. 440 2000 337 350
18. M.J. Dresser, M.K. Leabman, and K.M. Giacomini Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters J. Pharm. Sci. 90 2001 397 421
19. A.H. Dantzig Oral absorption of beta-lactams by intestinal peptide transport proteins Adv. Drug Deliv. Rev. 23 1997 63 76
20. C. Shu, H. Shen, U. Hopfer, and D.E. Smith Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures Drug Metab. Dispos. 29 2001 1307 1315
21. T. Zhu, X.Z. Chen, A. Steel, M.A. Hediger, and D.E. Smith Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2 Pharm. Res. 17 2000 526 532